Humacyte, Inc. Subsidiaries
Every subsidiary the company listed in Exhibit 21 of its annual reports, newest list first (2 lists). Names and jurisdictions are as filed.
- 2026-03-27: Subsidiary Humacyte Global, Inc..
- 2026-03-27: Subsidiary Humacyte Europe Limited.
- 2025-03-31: Subsidiary Document.
- 2025-03-31: Subsidiary Humacyte Global, Inc..
| Annual report filed | Subsidiary | Jurisdiction |
|---|---|---|
| 2026-03-27 | Humacyte Global, Inc. | |
| 2026-03-27 | Humacyte Europe Limited | |
| 2025-03-31 | Document | |
| 2025-03-31 | Humacyte Global, Inc. | |
| 2025-03-31 | Humacyte Europe Limited |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B | |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |